Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Rhenman & Partners Asset Management AB 13F Holdings -- Portfolio & Top Positions (2026-06-30)

Rhenman & Partners Asset Management AB (CIK 1599882) reported $1.06B across 99 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: UNH ($38.9M, 3.67%), CVS ($28.9M, 2.73%), AZN ($28.5M, 2.69%), MRK ($27.4M, 2.59%), LLY ($26.8M, 2.53%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1UNHUNITED HEALTH GROUP INC$38.9M3.67%93,600Added
2CVSCVS HEALTH CORP$28.9M2.73%279,374Trimmed
3AZNASTRAZENECA PLC$28.5M2.69%151,500New
4MRKMERCK & CO INC$27.4M2.59%213,500New
5LLYLILLY ELI & CO$26.8M2.53%22,315Trimmed
6ABBVABBVIE INC$24.4M2.30%96,775Added
7ALHCALIGNMENT HEALTHCARE INC$23.7M2.24%997,083Trimmed
8EWEDWARDS LIFESCIENCES CORP$23.5M2.22%260,000Added
9GILDGILEAD SCIENCES INC$22.5M2.13%178,250Added
10JAZZJAZZ PHARMACEUTICALS PLC$21.1M1.99%87,440Added
11BIIBBIOGEN INC$20.5M1.93%94,850Trimmed
12SYKSTRYKER CORPORATION$20.5M1.93%65,000Added
13BSXBOSTON SCIENTIFIC CORP$19.2M1.81%450,500Trimmed
14JNJJOHNSON & JOHNSON$18.4M1.74%72,500New
15GHGUARDANT HEALTH INC$17.3M1.63%115,000Trimmed
16REGNREGENERON PHARMACEUTICALS$17.1M1.61%27,390Trimmed
17NRIXNURIX THERAPEUTICS INC$16.6M1.57%684,250Added
18GKOSGLAUKOS CORP$16.6M1.57%119,000Added
19BMRNBIOMARIN PHARMACEUTICAL INC$16.6M1.57%290,500Added
20NTRANATERA INC$16.6M1.56%61,050Added
21MIRMMIRUM PHARMACEUTICALS INC$16.3M1.54%139,205Added
22INSMINSMED INC$16.2M1.53%151,960Trimmed
23THCTENET HEALTHCARE CORP$15.9M1.50%85,200Added
24TMOTHERMO FISHER SCIENTIFIC INC$15.8M1.49%31,580Trimmed
25CNCCENTENE CORP DEL$15.7M1.48%244,000New

Source: SEC Form 13F filings · as of 2026-06-30